ENG/中
美国
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerGPT
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
CAR-T
1,382.59
+5.93
0.43%
漲家數:
3
跌家數:
- -
平家數:
- -
市盈率:
- -
高:
1,396.81
開:
1,376.83
低:
1,376.83
收:
1,376.66
資料載入中...
總覽
新聞資訊
【歐股“十一羅漢”|諾和諾德收漲超1.4%,阿斯麥漲約0.5%】週一,阿斯麥控股荷蘭阿姆斯特丹股價收漲0.48%,報713.50歐元。諾和諾德哥本哈根股價收漲1.46%,報639.20。雀巢收漲3.15%,葛蘭素史克漲1.65%,阿斯利康、歐萊雅、諾華、德國思愛普Sap漲0.55%-0.26%。羅氏製藥和賽諾菲則至多收跌0.71%,LVMH集團跌1.47%。此外,歐洲芯片概念股普跌,BE半導體實業收跌2.17%,英飛凌、意法半導體至多跌1.29%,德國愛思強則漲1.76%。
金融界
·
02-25
藍鳥生物盤中異動 早盤大幅下跌6.00%報3.84美元
市场透视
·
02-24
吉利德科學(GILD.US)突破性小分子藥物獲歐盟批准 用於治療致命性肝病
智通财经
·
02-24
昌平區領導到北京諾華製藥有限公司昌平工廠走訪調研
北京时间
·
02-22
重磅!藍鳥生物被收購!
谈思生物
·
02-22
昔日千億市值獨角獸,被收購
生物科技馆
·
02-22
藍鳥生物股價重挫29.55% 市值跌1424.96萬美元
市场透视
·
02-21
BUZZ-藍鳥生物因與凱雷、SK Capital 達成折價私有化交易而下跌
路透中文
·
02-21
基因療法生產商藍鳥公司將在資金緊張的情況下通過折價交易實現私有化
路透中文
·
02-21
藍鳥生物同意被凱雷和 SK Capital 收購
路透中文
·
02-21
【歐股“十一羅漢”|歐萊雅和路易威登母公司收跌超2%,諾和諾德則漲約1.8%】 週三,阿斯麥控股荷蘭阿姆斯特丹股價收漲0.18%,報717.50歐元。諾和諾德哥本哈根股價收漲1.79%,報597.50。此外,歐萊雅收跌2.3%,LVMH集團跌2.01%,德國思愛普Sap、阿斯利康、賽諾菲、葛蘭素史克、羅氏製藥跌0.74%-0.07%,雀巢和諾華製藥則至多漲0.34%。歐洲奢侈品概念股普跌,除了上述歐萊雅與LVMH集團之外,雨果博斯收跌4.43%,博柏利跌3.05%,愛馬仕跌2.96%,斯沃琪集團和開雲集團至多跌1.74%,瑞士歷峯集團、人頭馬君度、保樂力加至多跌0.91%。
金融界
·
02-20
藍鳥生物盤中異動 早盤股價大跌5.20%報6.75美元
市场透视
·
02-19
吉利德(GILD.US)一年兩次長效HIV療法申報新適應症 HIV感染風險降低96%以上
智通财经
·
02-19
美國FDA優先受理吉利德預防HIV的新藥申請
金融界
·
02-19
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4578/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4578"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T","latestPrice":1382.588,"timestamp":1741208399999,"preClose":1376.6566,"halted":0,"volume":18213174,"delay":0,"changeRate":0.004309,"change":5.931396,"pbRate":5.765336,"amount":2063456275.663362,"amplitude":0.014515,"prevYearClose":1164.883,"fiveDayClose":1330.3182,"twentyDayClose":1252.4534,"turnoverRate":0.005809,"marketCap":364774630820,"floatMarketCap":354170504940,"peRate":30.124118},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1396.8141,"amplitude":0.014515,"preClose":1376.6566,"low":1376.8324,"pbRate":"5.765336","latestPrice":1382.588,"volume":18213174,"delay":0,"open":1376.8324,"prevYearClose":1164.883,"prevWeekClose":1356.2184,"prevMonthClose":1356.2184,"prevQuarterClose":1164.883,"fiveDayClose":1330.3182,"twentyDayClose":1252.4534,"sixtyDayClose":1190.7347,"secType":"PLATE","market":"US","turnoverRate":0.005809,"peRate":30.124118,"marketCap":364774630820,"floatMarketCap":354170504940,"timestamp":1741208399999,"nameCN":"CAR-T"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":3,"down":0,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:16,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514666774","title":"【歐股“十一羅漢”|諾和諾德收漲超1.4%,阿斯麥漲約0.5%】週一,阿斯麥控股荷蘭阿姆斯特丹股價收漲0.48%,報713.50歐元。諾和諾德哥本哈根股價收漲1.46%,報639.20。雀巢收漲3.15%,葛蘭素史克漲1.65%,阿斯利康、歐萊雅、諾華、德國思愛普Sap漲0.55%-0.26%。羅氏製藥和賽諾菲則至多收跌0.71%,LVMH集團跌1.47%。此外,歐洲芯片概念股普跌,BE半導體實業收跌2.17%,英飛凌、意法半導體至多跌1.29%,德國愛思強則漲1.76%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514666774","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514666774?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 01:50","pubTimestamp":1740419418,"startTime":"0","endTime":"0","summary":"周一,阿斯麦控股荷兰阿姆斯特丹股价收涨0.48%,报713.50欧元。诺和诺德哥本哈根股价收涨1.46%,报639.20。雀巢收涨3.15%,葛兰素史克涨1.65%,阿斯利康、欧莱雅、诺华、德国思爱普Sap涨0.55%-0.26%。罗氏制药和赛诺菲则至多收跌0.71%,LVMH集团跌1.47%。此外,欧洲芯片概念股普跌,BE半导体实业收跌2.17%,英飞凌、意法半导体至多跌1.29%,德国爱思强则涨1.76%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"be3201d4ba339139b8fa1c56337988b2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25015048358625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1829250122.USD","LU0444973449.USD","LU1093756168.USD","BK4599","IE0004445239.USD","IE00B2B36J28.USD","BK4578","LU1093756325.SGD","BK4182","159813","IE00BJJMRZ35.SGD","LU2063271972.USD","STM","LU0097036916.USD","BK4212","NVO","NSRGY","03165","LU0211331839.USD","LU2294711713.HKD","BK4568","LU1642822529.SGD","159582","BK4147","01477","BK4605","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IE00BMPRXN33.USD","BE","BK4541","AZN","GSK.UK","BK4554","BK4585","NVS","LRLCY","ASML","IE00BZ1G4Q59.USD","LU2236285917.USD","IE00BD6J9T35.USD","GSK","LU0109394709.USD","BK4141","LU0823434583.USD","BK4007","LU1815336760.USD","LU2506951792.HKD","LU0823434740.USD","LU2417539215.USD"],"gpt_icon":0},{"id":"2513722444","title":"藍鳥生物盤中異動 早盤大幅下跌6.00%報3.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513722444?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 22:33","pubTimestamp":1740407617,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时33分,蓝鸟生物股票出现波动,股价急速下跌6.00%。截至发稿,该股报3.84美元/股,成交量24.78万股,换手率2.54%,振幅2.72%。机构评级方面,在所有7家参与评级的机构中,14%的券商给予买入建议,86%的券商给予持有建议,无券商给予卖出建议。蓝鸟生物股票所在的生物技术行业中,整体跌幅为0.01%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242233379890f5f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242233379890f5f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","BLUE","BK4578"],"gpt_icon":0},{"id":"2513626227","title":"吉利德科學(GILD.US)突破性小分子藥物獲歐盟批准 用於治療致命性肝病","url":"https://stock-news.laohu8.com/highlight/detail?id=2513626227","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513626227?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 09:07","pubTimestamp":1740359262,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,吉利德科学公司日前宣布,欧盟委员会已有条件批准seladelpar上市,与熊去氧胆酸联用,治疗对UDCA单药应答不足的原发性胆汁性胆管炎患者。Seladelpar已于2024年8月获得美国FDA的加速批准,用于治疗PBC。Seladelpar曾获得FDA授予的突破性疗法认定以及针对PBC患者的孤儿药资格,以及欧洲药品管理局授予的PRIME资格。作为FDA加速批准的一部分,吉利德承诺进行一项名为AFFIRM的确认性长期结局研究,该研究已在代偿期肝硬化患者中启动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253193.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"吉利德科学(GILD.US)突破性小分子药物获欧盟批准 用于治疗致命性肝病","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4568","LU0889565916.HKD","LU1066051498.USD","BK4578","IE00BKVL7J92.USD","IE00B3T34201.USD","BK4550","IE00B19Z3581.USD","BK4585","BK4583","LU2468319806.SGD","GILD","BK4532","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0320765992.SGD","LU1839511570.USD","LU0234570918.USD","LU0058720904.USD","LU1430594728.SGD","BK4566","IE00BZ1G4Q59.USD","LU1571399168.USD","LU2087621335.USD","IE00B7SZLL34.SGD","BK4588","IE00BSNM7G36.USD","BK4139","LU0109394709.USD","LU1066053197.SGD","LU1585245621.USD","IE0002270589.USD","LU2089984988.USD"],"gpt_icon":0},{"id":"2513817270","title":"昌平區領導到北京諾華製藥有限公司昌平工廠走訪調研","url":"https://stock-news.laohu8.com/highlight/detail?id=2513817270","media":"北京时间","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513817270?lang=zh_tw&edition=fundamental","pubTime":"2025-02-22 23:08","pubTimestamp":1740236880,"startTime":"0","endTime":"0","summary":"2月20日,围绕“优化营商环境,实现一季度‘开门红’”主题,区委书记甘靖中带队到北京诺华制药有限公司昌平工厂走访调研,倾听企业诉求,解决发展难题,并与北京诺华制药有限公司昌平工厂负责人张明座谈交流。甘靖中一行实地察看了北京诺华制药有限公司昌平工厂西侧地块现状,了解公司新厂区土地供应进展及后续建设计划等情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-02-22/doc-inemkshz3908112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NVS","IE0009355771.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0211331839.USD","01477","BK4578","IE00BJJMRZ35.SGD","BK4007","BK4585","BK4532","IE00B4R5TH58.HKD","BK1191","IE00B2B36J28.USD","BK1574","BK4588","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2513279513","title":"重磅!藍鳥生物被收購!","url":"https://stock-news.laohu8.com/highlight/detail?id=2513279513","media":"谈思生物","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513279513?lang=zh_tw&edition=fundamental","pubTime":"2025-02-22 19:00","pubTimestamp":1740222016,"startTime":"0","endTime":"0","summary":"根据协议条款,蓝鸟生物的股东将获得每股3.00美元的现金,以及每股或有价值权。然而,该交易需满足以下条件:获得蓝鸟生物大部分已发行股份的投标、获得必要的监管批准以及其他常规成交条件。蓝鸟生物的董事会已一致批准该协议,并建议股东投标其股份。交易完成后,蓝鸟将转为私营公司,其普通股将不再在任何公开市场交易。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222193457abd8979b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222193457abd8979b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4135","IE00BGHQF748.EUR","BK4139","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4556","BLUE","BK4578","CG"],"gpt_icon":1},{"id":"2513324053","title":"昔日千億市值獨角獸,被收購","url":"https://stock-news.laohu8.com/highlight/detail?id=2513324053","media":"生物科技馆","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513324053?lang=zh_tw&edition=fundamental","pubTime":"2025-02-22 10:17","pubTimestamp":1740190645,"startTime":"0","endTime":"0","summary":"明星Biotech蓝鸟生物,昔日千亿市值独角兽,最终还是选择了“卖身”。当地时间2月21日,蓝鸟生物宣布,将被全球投资公司凯雷和由SK Capital管理的基金收购。据外媒最新消息,根据协议条款,蓝鸟生物股东将获得每股3美元的现金,这意味着其股权价值为2916万美元;投资公司还提供了每股6.84美元的额外支付,这代表约6648万美元的付款,但条件是达到所约定的销售里程碑。最终总计,交易总额约1亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222101943abd83c24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222101943abd83c24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4578","BK4556","BK4139","BLUE"],"gpt_icon":1},{"id":"2513296386","title":"藍鳥生物股價重挫29.55% 市值跌1424.96萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513296386?lang=zh_tw&edition=fundamental","pubTime":"2025-02-21 22:31","pubTimestamp":1740148274,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分,蓝鸟生物股票出现异动,股价急速跳水29.55%。截至发稿,该股报4.96美元/股,成交量165.059万股,换手率16.98%,振幅1.25%。蓝鸟生物股票所在的生物技术行业中,整体涨幅为0.33%。其相关个股中,Osr Holdings, Inc.、Nkgen Biotech, Inc.、Acelyrin, Inc.涨幅较大,Nkgen Biotech, Inc.、Aditxt, Inc.、蓝鸟生物较为活跃,换手率分别为69.02%、60.21%、17.19%,振幅较大的相关个股有Osr Holdings, Inc.、Gain Therapeutics, Inc.、Windtree Therapeutics, Inc.,振幅分别为11.30%、10.21%、7.29%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223114abd7af49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223114abd7af49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4578","BLUE","BK4139","BK4556"],"gpt_icon":0},{"id":"2513926037","title":"BUZZ-藍鳥生物因與凱雷、SK Capital 達成折價私有化交易而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2513926037","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513926037?lang=zh_tw&edition=fundamental","pubTime":"2025-02-21 21:22","pubTimestamp":1740144142,"startTime":"0","endTime":"0","summary":"** BLUE 在 2024 年下跌了 69.8(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nL3T3PC14W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","CG","BLUE","BK4578","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4139","IE00BGHQF748.EUR","BK4135"],"gpt_icon":0},{"id":"2513262096","title":"基因療法生產商藍鳥公司將在資金緊張的情況下通過折價交易實現私有化","url":"https://stock-news.laohu8.com/highlight/detail?id=2513262096","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513262096?lang=zh_tw&edition=fundamental","pubTime":"2025-02-21 20:58","pubTimestamp":1740142714,"startTime":"0","endTime":"0","summary":"更新版 3-基因疗法生产商蓝鸟公司将在资金紧张的情况下通过折价交易实现私有化在第 6 和第 7 段添加分析师评论Sneha S K. 路透社2月21日 - 基因疗法生产商蓝鸟生物BLUE.O周五同意由凯雷集团CG.O和SK Capital Partners以折扣价私有化,在此之前,蓝鸟生物曾因基因疗法艰难的市场环境导致现金紧缩而长期挣扎。Skysona获批治疗一种罕见的神经系统疾病,Zynteglo获批治疗一种名为β-地中海贫血的血液疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nL3S3PC135:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","CG","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4135","BK4139","IE00BGHQF748.EUR","BK4578","BLUE"],"gpt_icon":0},{"id":"2513628602","title":"藍鳥生物同意被凱雷和 SK Capital 收購","url":"https://stock-news.laohu8.com/highlight/detail?id=2513628602","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513628602?lang=zh_tw&edition=fundamental","pubTime":"2025-02-21 20:36","pubTimestamp":1740141414,"startTime":"0","endTime":"0","summary":"蓝鸟生物同意被凯雷和 SK Capital 收购路透社2月21日 - 青鸟生物BLUE.O周五表示,该公司已与全球投资公司凯雷CG.O和SK Capital Partners管理的基金达成收购协议。 (为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nL3S3PC12D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","BK4135","CG","BK4139","BLUE","IE00B3QW5Z07.USD","BK4578","IE00BGHQF748.EUR","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2512480245","title":"【歐股“十一羅漢”|歐萊雅和路易威登母公司收跌超2%,諾和諾德則漲約1.8%】 週三,阿斯麥控股荷蘭阿姆斯特丹股價收漲0.18%,報717.50歐元。諾和諾德哥本哈根股價收漲1.79%,報597.50。此外,歐萊雅收跌2.3%,LVMH集團跌2.01%,德國思愛普Sap、阿斯利康、賽諾菲、葛蘭素史克、羅氏製藥跌0.74%-0.07%,雀巢和諾華製藥則至多漲0.34%。歐洲奢侈品概念股普跌,除了上述歐萊雅與LVMH集團之外,雨果博斯收跌4.43%,博柏利跌3.05%,愛馬仕跌2.96%,斯沃琪集團和開雲集團至多跌1.74%,瑞士歷峯集團、人頭馬君度、保樂力加至多跌0.91%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512480245","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512480245?lang=zh_tw&edition=fundamental","pubTime":"2025-02-20 01:45","pubTimestamp":1739987144,"startTime":"0","endTime":"0","summary":"周三,阿斯麦控股荷兰阿姆斯特丹股价收涨0.18%,报717.50欧元。诺和诺德哥本哈根股价收涨1.79%,报597.50。此外,欧莱雅收跌2.3%,LVMH集团跌2.01%,德国思爱普Sap、阿斯利康、赛诺菲、葛兰素史克、罗氏制药跌0.74%-0.07%,雀巢和诺华制药则至多涨0.34%。欧洲奢侈品概念股普跌,除了上述欧莱雅与LVMH集团之外,雨果博斯收跌4.43%,博柏利跌3.05%,爱马仕跌2.96%,斯沃琪集团和开云集团至多跌1.74%,瑞士历峰集团、人头马君度、保乐力加至多跌0.91%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/20014548268219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4543","LU0097036916.USD","LU0823434583.USD","LU0320765992.SGD","ASML","IE0004445239.USD","LU2456880835.USD","IE00BKVL7J92.USD","LU1734074674.USD","BK4183","GSK.UK","LVMUY","LU0154236417.USD","LRLCY","BK1191","BK4578","LU1093756325.SGD","LU0109394709.USD","LU1829250122.USD","BK4212","BK4588","LU2462157665.USD","IE00BZ1G4Q59.USD","LU2063271972.USD","BK4147","IE00B4R5TH58.HKD","NVS","LU0211331839.USD","IE00BD6J9T35.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","AZN","01477","GSK","BK4568","BK1574","LU0823434740.USD","BK4599","IE0009355771.USD","BK4007","03165","LU2236285917.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4532","IE00B2B36J28.USD","NSRGY","LU0889565916.HKD","BK4585","NVO"],"gpt_icon":0},{"id":"2512248655","title":"藍鳥生物盤中異動 早盤股價大跌5.20%報6.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512248655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512248655?lang=zh_tw&edition=fundamental","pubTime":"2025-02-19 23:12","pubTimestamp":1739977972,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时12分,蓝鸟生物股票出现异动,股价急速下挫5.20%。截至发稿,该股报6.75美元/股,成交量3.3504万股,换手率0.34%,振幅3.47%。机构评级方面,在所有10家参与评级的机构中,20%的券商给予买入建议,60%的券商给予持有建议,20%的券商给予卖出建议。蓝鸟生物股票所在的生物技术行业中,整体涨幅为0.47%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219231253a24c0468&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219231253a24c0468&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4578","BK4556","BLUE"],"gpt_icon":0},{"id":"2512041631","title":"吉利德(GILD.US)一年兩次長效HIV療法申報新適應症 HIV感染風險降低96%以上","url":"https://stock-news.laohu8.com/highlight/detail?id=2512041631","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512041631?lang=zh_tw&edition=fundamental","pubTime":"2025-02-19 21:11","pubTimestamp":1739970683,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,2月18日,吉利德宣布FDA已接受lenacapavir用于HIV暴露前预防的新药申请,PDUFA预定审批日期为2025年6月19日。吉利德首席医学官Dietmar Berger博士表示:“我们距离推出首个每半年一次的HIV预防疗法又近了一步。如果获批,lenacapavir将有助于改变需要或希望获得更多预防选择人们的生活。我们对lenacapavir在美国乃至全球HIV预防中可能产生的积极影响感到兴奋,这将支持我们实现‘让每个人、每个地方终结HIV流行病’的目标。”","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1251875.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"吉利德(GILD.US)一年两次长效HIV疗法申报新适应症 HIV感染风险降低96%以上","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BSNM7G36.USD","LU1430594728.SGD","LU2468319806.SGD","IE00B3T34201.USD","BK4585","BK4566","BK4583","LU0889565916.HKD","BK4588","LU1571399168.USD","BK4139","BK4532","BK4568","LU0234570918.USD","LU2087621335.USD","GILD","IE00BKVL7J92.USD","LU0109394709.USD","IE00BZ1G4Q59.USD","LU1066053197.SGD","IE00B19Z3581.USD","BK4578","LU1585245621.USD","LU1839511570.USD","LU0289739699.SGD","LU2089984988.USD","IE0002270589.USD","LU0320765992.SGD","LU0058720904.USD","BK4550","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU1066051498.USD"],"gpt_icon":0},{"id":"2512115881","title":"美國FDA優先受理吉利德預防HIV的新藥申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2512115881","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512115881?lang=zh_tw&edition=fundamental","pubTime":"2025-02-19 07:56","pubTimestamp":1739922993,"startTime":"0","endTime":"0","summary":"美国食品与药物管理局(FDA)周二表示,将优先受理吉利德科学公司(Gilead Science)一年两次Lenacapavir预防HIV的新药申请。Lenacapavir是吉利德科学公司开发的一款长效HIV-1衣壳抑制剂,此前已经用于治疗接受过多次治疗,并且对多种药物产生耐药性的HIV-1感染者。\n\n\r\n 责任编辑:栎树","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2025/02/19075648243812.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU2087621335.USD","BK4139","LU1571399168.USD","LU1585245621.USD","LU2089984988.USD","LU0058720904.USD","BK4550","IE00B7SZLL34.SGD","GILD","LU2468319806.SGD","BK4568","LU0289739699.SGD","BK4578","LU1066053197.SGD","LU0889565916.HKD","IE00BZ1G4Q59.USD","IE00B3T34201.USD","IE0002270589.USD","IE00BSNM7G36.USD","IE00B19Z3581.USD","LU1839511570.USD","BK4532","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","LU0234570918.USD","LU0320765992.SGD","LU0109394709.USD","BK4585","BK4583","BK4566","LU1430594728.SGD","BK4588","LU1066051498.USD"],"gpt_icon":0}],"pageSize":16,"totalPage":2,"pageCount":2,"totalSize":30}]}}